Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Desmoplastic small round cell tumors: Multimodality treatment and new risk factors.
Scheer M, Vokuhl C, Blank B, Hallmen E, von Kalle T, Münter M, Wessalowski R, Hartwig M, Sparber-Sauer M, Schlegel PG, Kramm CM, Kontny U, Spriewald B, Kegel T, Bauer S, Kazanowska B, Niggli F, Ladenstein R, Ljungman G, Jahnukainen K, Fuchs J, Bielack SS, Klingebiel T, Koscielniak E; Cooperative Weichteilsarkom Studiengruppe [CWS]. Scheer M, et al. Among authors: bielack ss. Cancer Med. 2019 Feb;8(2):527-542. doi: 10.1002/cam4.1940. Epub 2019 Jan 16. Cancer Med. 2019. PMID: 30652419 Free PMC article. Clinical Trial.
Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86).
Winkler K, Bielack S, Delling G, Salzer-Kuntschik M, Kotz R, Greenshaw C, Jürgens H, Ritter J, Kusnierz-Glaz C, Erttmann R, et al. Winkler K, et al. Cancer. 1990 Oct 15;66(8):1703-10. doi: 10.1002/1097-0142(19901015)66:8<1703::aid-cncr2820660809>3.0.co;2-v. Cancer. 1990. PMID: 2208024 Clinical Trial.
Prognostic relevance of increased angiogenesis in osteosarcoma.
Kreuter M, Bieker R, Bielack SS, Auras T, Buerger H, Gosheger G, Jurgens H, Berdel WE, Mesters RM. Kreuter M, et al. Among authors: bielack ss. Clin Cancer Res. 2004 Dec 15;10(24):8531-7. doi: 10.1158/1078-0432.CCR-04-0969. Clin Cancer Res. 2004. PMID: 15623635
Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
Kempf-Bielack B, Bielack SS, Jürgens H, Branscheid D, Berdel WE, Exner GU, Göbel U, Helmke K, Jundt G, Kabisch H, Kevric M, Klingebiel T, Kotz R, Maas R, Schwarz R, Semik M, Treuner J, Zoubek A, Winkler K. Kempf-Bielack B, et al. Among authors: bielack ss. J Clin Oncol. 2005 Jan 20;23(3):559-68. doi: 10.1200/JCO.2005.04.063. J Clin Oncol. 2005. PMID: 15659502
Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System.
Paulides M, Dörr HG, Stöhr W, Bielack S, Koscielniak E, Klingebiel T, Jürgens H, Bölling T, Willich N, Sauer R, Langer T, Beck JD; Late Effects Surveillance System. Paulides M, et al. Clin Endocrinol (Oxf). 2007 May;66(5):727-31. doi: 10.1111/j.1365-2265.2007.02813.x. Epub 2007 Mar 23. Clin Endocrinol (Oxf). 2007. PMID: 17381483
Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma.
Dantonello TM, Int-Veen C, Winkler P, Leuschner I, Schuck A, Schmidt BF, Lochbuehler H, Kirsch S, Hallmen E, Veit-Friedrich I, Bielack SS, Niggli F, Kazanowska B, Ladenstein R, Wiebe T, Klingebiel T, Treuner J, Koscielniak E. Dantonello TM, et al. Among authors: bielack ss. J Clin Oncol. 2008 Jan 20;26(3):406-13. doi: 10.1200/JCO.2007.12.2382. J Clin Oncol. 2008. PMID: 18202417
258 results